| Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations R Varela-Fernández, V Díaz-Tomé, A Luaces-Rodríguez, ... Pharmaceutics 12 (3), 269, 2020 | 234 | 2020 |
| Ophthalmic econazole hydrogels for the treatment of fungal keratitis V Díaz-Tomé, A Luaces-Rodríguez, J Silva-Rodríguez, S Blanco-Dorado, ... Journal of pharmaceutical sciences 107 (5), 1342-1351, 2018 | 51 | 2018 |
| 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease I Seoane-Viaño, N Gómez-Lado, H Lázare-Iglesias, X García-Otero, ... Biomedicines 8 (12), 563, 2020 | 44 | 2020 |
| Design, optimization, and characterization of lactoferrin-loaded chitosan/TPP and chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a pharmacological alternative for … R Varela-Fernandez, X Garcia-Otero, V Diaz-Tome, U Regueiro, ... ACS Applied Materials & Interfaces 13 (3), 3559-3575, 2021 | 40 | 2021 |
| Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery R Varela-Fernández, X García-Otero, V Díaz-Tomé, U Regueiro, ... European Journal of Pharmaceutics and Biopharmaceutics 172, 144-156, 2022 | 37 | 2022 |
| Development and characterization of a tacrolimus/hydroxypropyl-β-cyclodextrin eye drop X García-Otero, V Díaz-Tomé, R Varela-Fernández, M Martín-Pastor, ... Pharmaceutics 13 (2), 149, 2021 | 25 | 2021 |
| In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis V Díaz-Tomé, X García-Otero, R Varela-Fernández, M Martín-Pastor, ... International journal of pharmaceutics 597, 120318, 2021 | 23 | 2021 |
| Preclinical characterization and clinical evaluation of tacrolimus eye drops A Luaces-Rodriguez, R Tourino-Peralba, I Alonso-Rodriguez, ... European Journal of Pharmaceutical Sciences 120, 152-161, 2018 | 19 | 2018 |
| Mucoadhesive PLGA nanospheres and nanocapsules for lactoferrin controlled ocular delivery R Varela-Fernández, X García-Otero, V Díaz-Tomé, U Regueiro, ... Pharmaceutics 14 (4), 799, 2022 | 10 | 2022 |
| Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model X García-Otero, C Mondelo-García, F González, R Perez-Fernandez, ... Pharmaceutics 13 (10), 1737, 2021 | 7 | 2021 |
| Drug delivery to the posterior segment of the eye: Biopharmaceutic and pharmacokinetic considerations. Pharmaceutics. 2020; 12 (3): 269 R Varela-Fernández, V Díaz-Tomé, A Luaces-Rodríguez, ... | 5 | |
| Biopharmaceutical assessment of dexamethasone acetate-based hydrogels combining hydroxypropyl cyclodextrins and polysaccharides for ocular delivery R Mazet, X García-Otero, L Choisnard, D Wouessidjewe, V Verdoot, ... Pharmaceutics 12 (8), 717, 2020 | 4 | 2020 |
| Antifungal Combination Eye Drops for Fungal Keratitis Treatment V Díaz-Tomé, C Bendicho-Lavilla, X García-Otero, R Varela-Fernández, ... Pharmaceutics 15 (1), 35, 2022 | 3 | 2022 |
| PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model X García-Otero, C Mondelo-García, E Bandín-Vilar, N Gómez-Lado, ... International Journal of Pharmaceutics 627, 122261, 2022 | 3 | 2022 |
| Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence A Castro-Balado, E Bandín-Vilar, A Cuartero-Martínez, ... Pharmaceutics 14 (10), 2194, 2022 | 2 | 2022 |
| Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model. Pharmaceutics 2021, 13, 1737 X Garcia-Otero, C Mondelo-Garcia, F Gonzalez, R Perez-Fernandez, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 2 | 2021 |
| Compression pressure-induced synergy in xanthan and locust bean gum hydrogels. Effect in drug delivery M Gago-Guillán, X García-Otero, S Anguiano-Igea, FJ Otero-Espinar Journal of Drug Delivery Science and Technology 89, 105025, 2023 | 1 | 2023 |
| Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models L García-Varela, J Codesido, A Perez-Pedrosa, M Muñoz-González, ... International Journal of Pharmaceutics 652, 123795, 2024 | | 2024 |
| Therapeutic alternatives research for the treatment of ocular inflammatory diseases X García Otero Therapeutic alternatives research for the treatment of ocular inflammatory …, 2022 | | 2022 |
| Therapeutic alternatives for the treatment of ocular inflammatory diseases X García Otero | | 2022 |
Francisco J Otero EspinarUniversity of Santiago de CompostelaVerified email at usc.es
